Lisa Michelle Kallebo's most recent trade in Adc Therapeutics SA was a trade of 62,900 Common Shares done at an average price of $4.0 . Disclosure was reported to the exchange on Feb. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Lisa Michelle Kallebo | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 13 Feb 2026 | 62,900 | 133,657 | - | 4.0 | 250,971 | Common Shares |
| Adc Therapeutics SA | Lisa Michelle Kallebo | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 13 Feb 2026 | 5,433 | 128,224 | - | 4.0 | 21,678 | Common Shares |
| Adc Therapeutics SA | Lisa Michelle Kallebo | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.29 per share. | 06 Dec 2025 | 7,140 | 70,757 | - | 3.3 | 23,491 | Common Shares |
| Adc Therapeutics SA | Lisa Michelle Kallebo | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 41,900 | 77,897 | - | 1.6 | 67,459 | Common Shares |
| Adc Therapeutics SA | Lisa Michelle Kallebo | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 6,503 | 35,997 | - | 3.1 | 20,354 | Common Shares |